Trial Information
Current as of January 14, 2025
Completed
Keywords
ClinConnect Summary
Mightier is a video-game-based biofeedback intervention that capitalizes on children's love of video games to increase emotional awareness and facilitate emotion regulation practice through heart rate (HR) control. Each family receives a Mightier Kit (Mighty Band heart rate monitor and dedicated tablet), the Mightier App, online caregiver resources, and dedicated 1-on-1 support from a licensed clinician. The effectiveness of Mightier has been supported through several studies in children ages 8-18, specifically reducing symptoms of aggression, oppositional behavior, and parental stress. The...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Parent or caregivers have a child engaging with the heart rate biofeedback intervention Mightier
- Exclusion Criteria:
- • None
About Neuromotion Labs
Neuromotion Labs is a pioneering clinical trial sponsor dedicated to advancing neurotechnology and therapeutic solutions for neurological disorders. By leveraging cutting-edge research and innovative methodologies, the company aims to enhance patient outcomes through rigorous clinical studies that explore the efficacy and safety of novel interventions. With a commitment to collaboration and scientific excellence, Neuromotion Labs strives to bridge the gap between research and real-world application, ultimately improving the quality of life for individuals affected by neurological conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials